amended by adding at the end the following: (4) Analysis For each fiscal year, the Secretary shall include in the report an analysis of the following: (A) The difference between the number of abbreviated new drug applications filed and the number of approvals or complete response letters issued by the agency, accounting for— (i) such applications filed during one fiscal year for which a decision is not scheduled to be made until the following fiscal year